{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:59:45Z","timestamp":1792292385365,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.autrev.2020.102494","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:58:39Z","timestamp":1581595119000},"page":"102494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Gender-related differences in systemic sclerosis"],"prefix":"10.1016","volume":"19","author":[{"given":"Michael","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Pauling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Armstrong-James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Galdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Flurey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10103","key":"10.1016\/j.autrev.2020.102494_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.autrev.2020.102494_bb0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","article-title":"Systemic sclerosis","volume":"80","author":"Hughes","year":"2019","journal-title":"Br J Hosp Med"},{"issue":"11","key":"10.1016\/j.autrev.2020.102494_bb0015","doi-asserted-by":"crossref","first-page":"102396","DOI":"10.1016\/j.autrev.2019.102396","article-title":"Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18","author":"Henry","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2020.102494_bb0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-74-5-714","article-title":"Epidemiology of systemic sclerosis (scleroderma)","volume":"74","author":"Medsger","year":"1971","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0025-6196(12)60294-8","article-title":"Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979","volume":"60","author":"Michet","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2020.102494_bb0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00002281-199112000-00012","article-title":"Epidemiology of scleroderma","volume":"3","author":"Silman","year":"1991","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102494_bb0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/ard.53.8.502","article-title":"Systemic sclerosis in Iceland. A nationwide epidemiological study","volume":"53","author":"Geirsson","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0040","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1445-5994.1995.tb02854.x","article-title":"A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy","volume":"25","author":"Chandran","year":"1995","journal-title":"Aust NZ J Med"},{"issue":"8","key":"10.1016\/j.autrev.2020.102494_bb0045","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/art.1780390814","article-title":"Increased prevalence of systemic sclerosis in a native american tribe in oklahoma. Association with an amerindian HLA haplotype","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1445-5994.1999.tb01587.x","article-title":"Systemic sclerosis prevalence and mortality in Sydney 1974-88","volume":"29","author":"Englert","year":"1999","journal-title":"Aust NZ J Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0889-857X(05)70299-4","article-title":"Scleroderma epidemiology","volume":"22","author":"Mayes","year":"2006","journal-title":"Rheum Dis Clin N Am"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0060","article-title":"Risk factors for the development of systemic sclerosis: a systematic review of the literature","volume":"2","author":"Abbot","year":"2018","journal-title":"Rheumatol Adv Pract"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00371817","article-title":"Epidemiological study of patients with systemic sclerosis in Tokyo","volume":"283","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/rheumatology\/27.4.286","article-title":"An epidemiological study of scleroderma in the west midlands","volume":"27","author":"Silman","year":"1988","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.autrev.2020.102494_bb0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/rheumatology\/keh124","article-title":"A study of the prevalence of systemic sclerosis in northeast England","volume":"43","author":"Allcock","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2020.102494_bb0080","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","article-title":"The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink","volume":"37","author":"Royle","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102494_bb0085","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","article-title":"Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature","volume":"92","author":"Gelber","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0095","article-title":"Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA","volume":"30","author":"Nietert","year":"2003","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102494_bb0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12016-013-8392-9","article-title":"The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance","volume":"47","author":"D\u2019Amico","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2019.07.007","article-title":"Sex hormones and sex hormone-targeting therapies in systemic sclerosis: A systematic literature review","volume":"50","author":"Ciaffi","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.2002.tb04221.x","article-title":"Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis","volume":"966","author":"Scorza","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.autrev.2020.102494_bb0115","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar4587","article-title":"Group the CSR. Effect of menopause on the modified Rodnan skin score in systemic sclerosis","volume":"16","author":"Vinet","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102494_bb0120","article-title":"Estrogens counteract the profibrotic effects of TGFGF-\u03b2 and their inhibition exacerbates experimental dermal fibrosis","author":"Avouac","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-019-1870-6","article-title":"Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival","volume":"21","author":"Baker Frost","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/rheumatology\/keu432","article-title":"Androgens in post-menopausal patients with systemic sclerosis","volume":"54","author":"Perkovi\u0107","year":"2014","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/08916934.2014.968918","article-title":"Associations between Klinefelter\u2019s syndrome and autoimmune diseases: English national record linkage studies","volume":"48","author":"Seminog","year":"2015","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.autrev.2020.102494_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2249.2012.04621.x","article-title":"X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma","volume":"169","author":"Selmi","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102494_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2010.129999","article-title":"Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis","volume":"69","author":"Broen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2020.102494_bb0150","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/art.30640","article-title":"Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: Association with the functional IRAK1 196Phe\/532Ser haplotype","volume":"63","author":"Dieud\u00e9","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1(4)","key":"10.1016\/j.autrev.2020.102494_bb0155","first-page":"68","article-title":"Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database","volume":"36","author":"Carreira","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102494_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-202742","article-title":"New insight on the Xq28 association with systemic sclerosis","volume":"72","author":"Carmona","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102494_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2018.10.002","article-title":"Impact of alterations in X-linked IRAK1gene and miR-146a on susceptibility and clinical manifestations in patients with systemic sclerosis","volume":"204","author":"Vreca","year":"2018","journal-title":"Immunol Lett"},{"issue":"10","key":"10.1016\/j.autrev.2020.102494_bb0170","article-title":"IL13RA2 gene polymorphisms are associated with systemic sclerosis","volume":"33","author":"Granel","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102494_bb0175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.3643","article-title":"A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases","volume":"18","author":"Liang","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102494_bb0180","article-title":"Relationship between parity and clinical and biological features in patients with systemic sclerosis","volume":"28","author":"Launay","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis","volume":"31","author":"Steen","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2020.102494_bb0195","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","article-title":"Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies","volume":"30","author":"Krzyszczak","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1346-8138.12722","article-title":"Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies","volume":"42","author":"Motegi","year":"2015","journal-title":"J Dermatol"},{"issue":"Suppl 106(4)","key":"10.1016\/j.autrev.2020.102494_bb0205","first-page":"89","article-title":"Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review","volume":"35","author":"Freire","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0210","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.semarthrit.2014.11.006","article-title":"Antinuclear antibody-negative systemic sclerosis","volume":"44","author":"Salazar","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"6 Suppl 86","key":"10.1016\/j.autrev.2020.102494_bb0215","article-title":"And The Canadian Scleroderma Research Group A. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry","volume":"32","author":"Delisle","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.24284","article-title":"Time to diagnosis in systemic sclerosis: Is sex a factor?","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5301\/jsrd.5000209","article-title":"Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes","volume":"1","author":"Peoples","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3899\/jrheum.120667","article-title":"Is vasculopathy associated with systemic sclerosis more severe in men?","volume":"40","author":"Panopoulos","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","article-title":"Systemic sclerosis and exposure to heavy metals","volume":"18","author":"Marie","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2020.102494_bb0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: A case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2020.102494_bb0245","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3899\/jrheum.081044","article-title":"Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: Post-hoc analysis of a nationwide multicenter cohort (Itin\u00e9rAIR-Scl\u00e9rodermie)","volume":"36","author":"Tiev","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/CH-141809","article-title":"Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters","volume":"59","author":"Manfredi","year":"2015","journal-title":"Clin Hemorheol Microcirc"},{"issue":"5","key":"10.1016\/j.autrev.2020.102494_bb0255","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.24394","article-title":"Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients","volume":"61","author":"Sebastiani","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2020.102494_bb0260","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s10067-018-4148-5","article-title":"Vascular complications in systemic sclerosis: a prospective cohort study","volume":"37","author":"Mecoli","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","article-title":"Digital ulcers in systemic sclerosis","volume":"56","author":"Hughes","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0270","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian scleroderma research group registry","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"2 Suppl 76","key":"10.1016\/j.autrev.2020.102494_bb0275","first-page":"46","article-title":"Clinical characteristics of systemic sclerosis patients with digital ulcers in China","volume":"31","author":"Xu","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2016.04.001","article-title":"Raynaud\u2019s phenomenon","volume":"30","author":"Hughes","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102494_bb0285","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3899\/jrheum.141437","article-title":"Use of laser speckle contrast imaging to assess digital microvascular function in primary raynaud phenomenon and systemic sclerosis: a comparison using the raynaud condition score diary","volume":"42","author":"Pauling","year":"2015","journal-title":"J. Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102494_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-209481","article-title":"Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort","volume":"75","author":"Allanore","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","article-title":"A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Elhai","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2020.102494_bb0305","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.autrev.2018.03.015","article-title":"Subclinical cardiovascular disease and Systemic Sclerosis: A comparison between risk charts, quantification of coronary calcium and carotid ultrasonography","volume":"17","author":"Sanz P\u00e9rez","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0310","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.autrev.2018.09.002","article-title":"Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association","volume":"18","author":"Zanatta","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2020.102494_bb0315","doi-asserted-by":"crossref","first-page":"e17551","DOI":"10.1371\/journal.pone.0017551","article-title":"Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis","volume":"6","author":"Nguyen","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0320","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0325","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffman-Void","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102494_bb0330","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.140006","article-title":"The effect of male sex on survival in systemic sclerosis","volume":"41","author":"Hussein","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102494_bb0335","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211480","article-title":"Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort","volume":"77","author":"Mihai","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0340","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/03009740600844498","article-title":"Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"35","author":"Beretta","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102494_bb0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-016-0933-1","article-title":"Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study","volume":"18","author":"Pasarikovski","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2020.102494_bb0350","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","article-title":"Therapy of scleroderma renal crisis: state of the art","volume":"17","author":"Zanatta","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102494_bb0355","doi-asserted-by":"crossref","first-page":"102403","DOI":"10.1016\/j.autrev.2019.102403","article-title":"Is there today a place for corticosteroids in the treatment of scleroderma?","author":"Blagojevic","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2020.102494_bb0360","doi-asserted-by":"crossref","first-page":"e0163894","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl 1(4)","key":"10.1016\/j.autrev.2020.102494_bb0365","first-page":"82","article-title":"Severe oesophageal disease and its associations with systemic sclerosis","volume":"35","author":"Karamanolis","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102494_bb0370","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/rheumatology\/kex230","article-title":"The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study","volume":"56","author":"John","year":"2017","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0375","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.semarthrit.2004.08.006","article-title":"Osteoporosis in scleroderma","volume":"34","author":"Loucks","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0380","article-title":"Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions","volume":"35","author":"Saiyan","year":"2008","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0385","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/rheumatology\/kes240","article-title":"Prevalence and risk factors of low bone mineral density in Chinese patients with systemic sclerosis: a case\u2013control study","volume":"52","author":"Mok","year":"2012","journal-title":"Rheumatology"},{"issue":"17","key":"10.1016\/j.autrev.2020.102494_bb0390","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.18632\/oncotarget.3806","article-title":"Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a case-control study","volume":"6","author":"Marot","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.autrev.2020.102494_bb0395","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-204832","article-title":"Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study","volume":"74","author":"Lai","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2020.102494_bb0400","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.121390","article-title":"Survival and causes of death in an unselected and complete cohort of norwegian patients with systemic sclerosis","volume":"40","author":"Hoffmann-Vold","year":"2013","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102494_bb0405","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.autrev.2018.02.008","article-title":"Predictors of morbidity and mortality in early systemic sclerosis: long-term follow-up data from a single-centre inception cohort","volume":"17","author":"Panopoulos","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2020.102494_bb0410","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10067-013-2289-0","article-title":"Mortality in systemic sclerosis\u2014a single centre study from the UK","volume":"32","author":"Strickland","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102494_bb0415","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis\u2013associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lef\u00e8vre","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2020.102494_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0465","first-page":"50","article-title":"Development of systemic sclerosis in transgender females: a case series and review of the literature","volume":"36 Suppl 113","author":"Campochiaro","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0425","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/pubmed\/fdr006","article-title":"Short Form 36 (SF-36) Health Survey Questionnaire: normative data for Wales","volume":"33","author":"Burholt","year":"2011","journal-title":"J Public Health (Bangkok)"},{"issue":"5","key":"10.1016\/j.autrev.2020.102494_bb0430","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10067-014-2525-2","article-title":"Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case\u2013control study","volume":"33","author":"Chan","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102494_bb0435","doi-asserted-by":"crossref","first-page":"e90484","DOI":"10.1371\/journal.pone.0090484","article-title":"Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey","volume":"9","author":"Nguyen","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.autrev.2020.102494_bb0440","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/occmed\/kqu024","article-title":"The hospital anxiety and depression scale","volume":"64","author":"Stern","year":"2014","journal-title":"Occup Med (Chic Ill)"},{"issue":"4","key":"10.1016\/j.autrev.2020.102494_bb0445","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/s10165-010-0285-7","article-title":"Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors","volume":"20","author":"Ostojic","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102494_bb0450","series-title":"BDI, Beck depression inventory: manual","author":"Beck","year":"1987"},{"issue":"6","key":"10.1016\/j.autrev.2020.102494_bb0455","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0033-3182(71)71479-0","article-title":"A rating instrument for anxiety disorders","volume":"12","author":"Zung","year":"1971","journal-title":"Psychosomatics"},{"issue":"Suppl 100(5)","key":"10.1016\/j.autrev.2020.102494_bb0460","first-page":"70","article-title":"African American race associated with body image dissatisfaction among patients with systemic sclerosis","volume":"34","author":"Nusbaum","year":"2013","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:36Z","timestamp":1761599856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220300422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1568997220300422"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102494","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender-related differences in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102494"}}